Differential expression and regulation of vitamin D hydroxylases and inflammatory genes in prostate stroma and epithelium by 1,25-dihydroxyvitamin D in men with prostate cancer and an in vitro model

Journal of Steroid Biochemistry and Molecular Biology

Volumn 148, Issue , 2015, Pages 156-165

  Giangreco, Angeline A ^a   Dambal, Shweta ^a   Wagner, Dennis ^b   Van Der Kwast, Theodorus ^c   Vieth, Reinhold ^b   Prins, Gail S ^a   Nonn, Larisa ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b University of Illinois Cancer Center ^*  (United States)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CHOLESTANETRIOL 26 MONOOXYGENASE; COLECALCIFEROL; COLECALCIFEROL 24 HYDROXYLASE; CYCLOOXYGENASE 2; CYTOCHROME P450; CYTOCHROME P450 27B1; CYTOCHROME P450 2R1; INTERLEUKIN 6; INTERLEUKIN 8; OXYGENASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VITAMIN D HYDROXYLASE; VITAMIN D RECEPTOR; AUTACOID; CALCITRIOL RECEPTOR; MESSENGER RNA; STEROID MONOOXYGENASE; VITAMIN;

ARTICLE; CANCER PATIENT; CONTROLLED STUDY; CYTOKINE RELEASE; EPITHELIUM CELL; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATECTOMY; PROTEIN EXPRESSION; STROMA CELL; VITAMIN D METABOLISM; CELL CULTURE; CELL PROLIFERATION; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECTS; EPITHELIUM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PHASE 2 CLINICAL TRIAL (TOPIC); PROSTATE; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CALCITRIOL; CELL PROLIFERATION; CELLS, CULTURED; CLINICAL TRIALS, PHASE II AS TOPIC; EPITHELIUM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN VITRO TECHNIQUES; INFLAMMATION MEDIATORS; MALE; PROSTATE; PROSTATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CALCITRIOL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEROID HYDROXYLASES; STROMAL CELLS; VITAMINS;

EID: 84925498867     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2014.10.004     Document Type: Article

References (49)

1. D. Feldman, A.V. Krishnan, S. Swami, E. Giovannucci, and B.J. Feldman The role of vitamin D in reducing cancer risk and progression Nat. Rev. Cancer 14 2014 342 357
2. A.V. Krishnan, D.M. Peehl, and D. Feldman Inhibition of prostate cancer growth by vitamin D: regulation of target gene expression J. Cell. Biochem. 88 2003 363 371
3. W.F. Rigby, R.J. Noelle, K. Krause, and M.W. Fanger The effects of 1,25-dihydroxyvitamin D3 on human T lymphocyte activation and proliferation: a cell cycle analysis J. Immunol. 135 1985 2279 2286
4. S.E. Blutt, T.J. McDonnell, T.C. Polek, and N.L. Weigel Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2 Endocrinology 141 2000 10 17
5. J. Moreno, A.V. Krishnan, and D. Feldman Molecular mechanisms mediating the anti-proliferative effects of vitamin D in prostate cancer J. Steroid Biochem. Mol. Biol. 97 2005 31 36
6. L. Nonn, L. Peng, D. Feldman, and D.M. Peehl Inhibition of p38 by vitamin D reduces interleukin-6 production in normal prostate cells via mitogen-activated protein kinase phosphatase 5: implications for prostate cancer prevention by vitamin D Cancer Res. 66 2006 4516 4524
7. G. Penna, S. Amuchastegui, C. Cossetti, F. Aquilano, R. Mariani, F. Sanvito, C. Doglioni, and L. Adorini Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin D receptor agonist elocalcitol J. Immunol. 177 2006 8504 8511
8. G.R. Cunha, P.S. Cooke, and T. Kurita Role of stromal-epithelial interactions in hormonal responses Arch. Histol. Cytol. 67 2004 417 434
9. J.A. Tuxhorn, G.E. Ayala, and D.R. Rowley Reactive stroma in prostate cancer progression J. Urol. 166 2001 2472 2483
10. D.A. Barron, and D.R. Rowley The reactive stroma microenvironment and prostate cancer progression Endocr. Relat. Cancer 19 2012 R187 R204
11. S. Ostrand-Rosenberg Immune surveillance: a balance between protumor and antitumor immunity Curr. Opin. Genet. Dev. 18 2008 11 18
12. S.J. Galli, N. Borregaard, and T.A. Wynn Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils Nat. Immunol. 12 2011 1035 1044
13. M. Gleave, J.T. Hsieh, C.A. Gao, A.C. von Eschenbach, and L.W. Chung Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts Cancer Res. 51 1991 3753 3761
14. J.L. Camps, S.M. Chang, T.C. Hsu, M.R. Freeman, S.J. Hong, H.E. Zhau, A.C. von Eschenbach, and L.W. Chung Fibroblast-mediated acceleration of human epithelial tumor growth in vivo Proc. Natl. Acad. Sci. U. S. A. 87 1990 75 79
15. L.W. Chung, and R. Davies Prostate epithelial differentiation is dictated by its surrounding stroma Mol. Biol. Rep. 23 1996 13 19
16. Y. Nakai, and N. Nonomura Inflammation and prostate carcinogenesis Int. J. Urol. 20 2013 150 160
17. K.S. Sfanos, and A.M. De Marzo Prostate cancer and inflammation: the evidence Histopathology 60 2012 199 215
18. L.K. Dennis, C.F. Lynch, and J.C. Torner Epidemiologic association between prostatitis and prostate cancer Urology 60 2002 78 83
19. A.M. De Marzo, V.L. Marchi, J.I. Epstein, and W.G. Nelson Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis Am. J. Pathol. 155 1999 1985 1992
20. C.R. Bethel, D. Faith, X. Li, B. Guan, J.L. Hicks, F. Lan, R.B. Jenkins, C.J. Bieberich, and A.M. De Marzo Decreased NKX3. 1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion Cancer Res. 66 2006 10683 10690
21. A.M. De Marzo, Y. Nakai, and W.G. Nelson Inflammation, atrophy, and prostate carcinogenesis Urol. Oncol. 25 2007 398 400
22. A.A. Hidalgo, R. Paredes, V.M. Garcia, G. Flynn, C.S. Johnson, D.L. Trump, and S.A. Onate Altered VDR-mediated transcriptional activity in prostate cancer stroma J. Steroid Biochem. Mol. Biol. 103 2007 731 736
23. A.M. Barreto, G.G. Schwartz, R. Woodruff, and S.D. Cramer 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells Cancer Epidemiol. Biomarkers Prev. 9 2000 265 270
24. D. Krill, P. DeFlavia, R. Dhir, J.M.J. Luo Becich, E. Lehman, and R.H. Getzenberg Expression patterns of vitamin D receptor in human prostate J. Cell. Biochem. 82 2001 566 572
25. A.A. Giangreco, A. Vaishnav, D. Wagner, A. Finelli, N. Fleshner, T. Van der Kwast, R. Vieth, and L. Nonn Tumor suppressor microRNAs, miR-100 and -125b, are regulated by 1,25-dihydroxyvitamin D in primary prostate cells and in patient tissue Cancer Prev. Res. 2013
26. D. Wagner, D. Trudel, T. Van der Kwast, L. Nonn, A.A. Giangreco, D. Li, A. Dias, M. Cardoza, S. Laszlo, K. Hersey, L. Klotz, A. Finelli, N. Fleshner, and R. Vieth Randomized clinical trial of vitamin d3 doses on prostatic vitamin d metabolite levels and ki67 labeling in prostate cancer patients J. Clin. Endocrinol. Metab. 98 2013 1498 1507
27. D.M. Peehl Are primary cultures realistic models of prostate cancer? J. Cell. Biochem. 91 2004 185 195
28. W.Y. Hu, G.B. Shi, H.M. Lam, D.P. Hu, S.M. Ho, I.C. Madueke, A. Kajdacsy-Balla, and G.S. Prins Estrogen-initiated transformation of prostate epithelium derived from normal human prostate stem-progenitor cells Endocrinology 152 2011 2150 2163
29. L. Nonn, A. Vaishnav, L. Gallagher, and P.H. Gann mRNA and micro-RNA expression analysis in laser-capture microdissected prostate biopsies: valuable tool for risk assessment and prevention trials Exper. Mol. Pathol. 88 2010 45 51
30. H.W. Prins, G.S. Shi, G.B. Hu, D.P. Majumdar, S. Li, G. Nelles, J. Ho, S.M. Walker, C.L. Kajdacsy-Balla, and A.R. vanBreeman Bisphenol a promotes human prostate stem-progenitor cell self-renewal and increases in vivo carcinogenesis in human prostate epithelium Endocrinology 155 2014 805 817
31. R. Kalluri, and M. Zeisberg Fibroblasts in cancer Nat. Rev. Cancer 6 2006 392 401
32. J. Haverkamp, B. Charbonneau, and T.L. Ratliff Prostate inflammation and its potential impact on prostate cancer: a current review J. Cell. Biochem. 103 2008 1344 1353
33. L. Nonn, D. Duong, and D.M. Peehl Chemopreventive anti-inflammatory activities of curcumin and other phytochemicals mediated by MAP kinase phosphatase-5 in prostate cells Carcinogenesis 28 2007 1188 1196
34. Y. Bostanci, A. Kazzazi, S. Momtahen, J. Laze, and B. Djavan Correlation between benign prostatic hyperplasia and inflammation Curr. Opin. Urol. 23 2013 5 10
35. S.W. Hayward, M.A. Rosen, and G.R. Cunha Stromal-epithelial interactions in the normal and neoplastic prostate Br. J. Urol. 79 Suppl. 2 1997 18 26
36. E.A. Ricke, K. Williams, Y.F. Lee, S. Couto, Y. Wang, S.W. Hayward, G.R. Cunha, and W.A. Ricke Androgen hormone action in prostatic carcinogenesis: stromal androgen receptors mediate prostate cancer progression, malignant transformation and metastasis Carcinogenesis 33 2012 1391 1398
37. G. Risbridger, H. Wang, P. Young, T. Kurita, Y.Z. Wang, D. Lubahn, J.A. Gustafsson, and G. Cunha Evidence that epithelial and mesenchymal estrogen receptor-alpha mediates effects of estrogen on prostatic epithelium Dev. Biol. 229 2001 432 442
38. D.M. Peehl, R.J. Skowronski, G.K. Leung, S.T. Wong, T.A. Stamey, and D. Feldman Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells Cancer Res. 54 1994 805 810
39. A. Hobisch, H. Rogatsch, A. Hittmair, D. Fuchs, G. Bartsch Jr., H. Klocker, G. Bartsch, and Z. Culig Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue J. Pathol. 191 2000 239 244
40. M.R. Cardillo, and F. Ippoliti IL-6, IL-10 and HSP-90 expression in tissue microarrays from human prostate cancer assessed by computer-assisted image analysis Anticancer Res. 26 2006 3409 3416
41. D.P. Nguyen, J. Li, and A.K. Tewari Inflammation and prostate cancer: the role of interleukin-6 BJU Int. 113 2014 986 992
42. V. Michalaki, K. Syrigos, P. Charles, and J. Waxman Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer Br. J. Cancer 90 2004 2312 2316
43. L.W. Whitlatch, M.V. Young, G.G. Schwartz, J.N. Flanagan, K.L. Burnstein, B.L. Lokeshwar, E.S. Rich, M.F. Holick, and T.C. Chen 25-Hydroxyvitamin D-1alpha-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer J. Steroid Biochem. Mol. Biol. 81 2002 135 140
44. J.Y. Hsu, D. Feldman, J.E. McNeal, and D.M. Peehl Reduced 1alpha-hydroxylase activity in human prostate cancer cells correlates with decreased susceptibility to 25-hydroxyvitamin D3-induced growth inhibition Cancer Res. 61 2001 2852 2856
45. R. Kumar, D.N. Iachini, P.M. Neilsen, J. Kaplan, J. Michalakas, P.H. Anderson, B.K. May, H.A. Morris, and D.F. Callen Systematic characterisation of the rat and human CYP24A1 promoter Mol. Cell. Endocrinol. 325 2010 46 53
46. A. Gozdzik, J. Zhu, B.Y. Wong, L. Fu, D.E. Cole, and E.J. Parra Association of vitamin D binding protein (VDBP) polymorphisms and serum 25(OH)D concentrations in a sample of young Canadian adults of different ancestry J. Steroid Biochem. Mol. Biol. 127 2011 405 412
47. J.J. McGrath, S. Saha, T.H. Burne, and D.W. Eyles A systematic review of the association between common single nucleotide polymorphisms and 25-hydroxyvitamin D concentrations J Steroid Biochem. Mol. Biol. 121 2010 471 477
48. J.R. Muindi, A.A. Adjei, Z.R. Wu, I. Olson, H. Huang, A. Groman, L. Tian, P.K. Singh, L.E. Sucheston, C.S. Johnson, D.L. Trump, and M.G. Fakih Serum vitamin D metabolites in colorectal cancer patients receiving cholecalciferol supplementation: correlation with polymorphisms in the vitamin D genes Hormones Cancer 4 2013 242 250
49. K.D. Healy, J.B. Zella, J.M. Prahl, and H.F. DeLuca Regulation of the murine renal vitamin D receptor by 1,25-dihydroxyvitamin D3 and calcium Pro. Natl. Acad. Sci. U. S. A. 100 2003 9733 9737